Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer.
暂无分享,去创建一个
I. Thompson | H. Levin | E. Klein | D. Svetec | S. Optenberg | S. Peretsman | K. McCabe | I. Thompson
[1] P. Walsh,et al. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. , 1997, The Journal of urology.
[2] R. Abrams,et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. , 1995, Urology.
[3] G. Perry,et al. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. , 1995, Urology.
[4] R. B. Smith,et al. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. , 1994, The Journal of urology.
[5] P C Prorok,et al. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. , 1994, The Journal of urology.
[6] F. Lee,et al. US-guided percutaneous cryoablation of prostate cancer. , 1994, Radiology.
[7] W. Catalona,et al. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. , 1994, The Journal of urology.
[8] A. Zietman,et al. Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome. , 1994, The Journal of urology.
[9] Boris Rubinsky,et al. Transrectal ultrasound‐guided percutaneous radical cryosurgical ablation of the prostate , 1993, Cancer.
[10] M. Terris,et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.
[11] H. Stricker,et al. Detection of non-palpable prostate cancer. A mathematical and laboratory model. , 1993, British journal of urology.